Patent · US Active

Diagnostic system

US12310730B2 · kind B2 · utility

0Cited by
203References
28Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 14, 2021
Grant dateMay 27, 2025
Priority date
Expiry dateNov 30, 2043

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N35/00029
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Methods and systems are provided for point-of-care nucleic acid amplification and detection. One embodiment of the point-of-care molecular diagnostic system includes a cartridge and an instrument. The cartridge can accept a biological sample, such as a urine or blood sample. The cartridge, which can comprise one or more of a loading module, lysis module, purification module and amplification module, is inserted into the instrument which acts upon the cartridge to facilitate various sample processing steps that occur in order to perform a molecular diagnostic test.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.